Lithium augmentation compared with phenelzine in treatment-resistant depression in the elderly: An open, randomized, controlled trial

Journal of Clinical Psychiatry

Volumn 68, Issue 8, 2007, Pages 1177-1185

  Kok, Rob M ^a   Vink, Dagmar ^b   Heeren, Thea J ^c,d   Nolen, Willem A ^e  

^a Altrecht Institute of Mental Health Care   (Netherlands)

^b Knowledge Centre of Psychiatry in the Elderly   (Netherlands)

^c Symfora Group Centers of Mental Health Care   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; LITHIUM; NORTRIPTYLINE; OXAZEPAM; PHENELZINE; RISPERIDONE; TEMAZEPAM; VENLAFAXINE;

AGITATION; AKATHISIA; ANXIETY; APPETITE; ARTICLE; BLURRED VISION; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIARRHEA; DISEASE COURSE; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; DYSTONIA; EXCITEMENT; FATIGUE; FEMALE; FOLLOW UP; HEADACHE; HUMAN; INSOMNIA; MAJOR DEPRESSION; MALE; MEMORY DISORDER; MICTURITION; NAUSEA AND VOMITING; NERVOUSNESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; RIGIDITY; SIDE EFFECT; SYNCOPE; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE; TREMOR; UNSPECIFIED SIDE EFFECT; WEAKNESS; WEIGHT GAIN; XEROSTOMIA;

EID: 34548586765     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/jcp.v68n0803     Document Type: Article

References (45)

1. Alexopoulos GS, Katz I, Reynolds CF, et al. Expert Consensus Panel for Pharmacotherapy of Depressive Disorders in Older Patients. Consensus panel for the expert consensus guideline series. Pharmacotherapy of depressive disorders in older patients. Postgrad Med 2001 (special issue): 1-86
2. Keller MB. Issues in treatment-resistant depression. J Clin Psychiatry 2005;66:5-12
3. World Psychiatric Association. Symposium on therapy resistant depression. Pharmacopsychiatry 1974;7:69-224
4. Stimpson N, Agrawal N, Lewis G. Randomised controlled trials investigating pharmacological and psychological interventions for treatment-refractory depression: systematic review. Br J Psychiatry 2002;181:284-294
5. Bauer M, Forsthoff A, Baethge C, et al. Lithium augmentation therapy in refractory depression-update 2002. Eur Arch Psychiatry Clin Neurosci 2003;253:132-139
6. McGrath PJ, Steward JW, Fava M, et al. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant trials for depression: a STAR*D report. Am J Psychiatry 2006;163:1531-1541
7. McGrath PJ, Stewart JW, Nunes EV, et al. A double-blind crossover trial of imipramine and phenelzine for outpatients with treatment-refractory depression. Am J Psychiatry 1993;150:118-123
8. Nolen WA, van de Putte JJ, Dijken WA, et al. Treatment strategy in depression, 2: MAO inhibitors in depression resistant to cyclic antidepressants: two controlled crossover studies with tranylcypromine versus L-5-hydroxytryptophan and nomifensine. Acta Psychiatr Scand 1988;78:676-683
9. Nolen WA, Haffmans PJ, Bouvy PF, et al. Monoamine oxidase inhibitors in resistant major depression: a double-blind comparison of brofaromine and tranylcypromine in patients resistant to tricyclic antidepressants. J Affect Disord 1993;28:189-197
10. Birkenhäger TK, van den Broek WW, Mulder PG, et al. Efficacy and tolerability of tranylcypromine versus phenelzine: a double-blind study in antidepressant-refractory depressed inpatients. J Clin Psychiatry 2004;65:1505-1510
11. Volz HP, Faltus F, Magyar I, et al. Brofaromine in treatment-resistant depressed patients: a comparative trial versus tranylcypromine. J Affect Disord 1994;30:209-217
12. Van der Wurff FB, Stek ML, Hoogendijk WL, et al. Electroconvulsive therapy for the depressed elderly. Cochrane Database Syst Rev 2003: CD003593
13. Manes F, Jorge R, Morcuende M, et al. A controlled study of repetitive transcranial magnetic stimulation as a treatment of depression in the elderly. Int Psychogeriatr 2001;13:225-231
14. Mosimann UP, Schmitt W, Greenberg BD, et al. Repetitive transcranial magnetic stimulation: a putative add-on treatment for major depression in elderly patients. Psychiatry Res 2004;126:123-133
15. Sunderland T, Cohen RM, Molchan S, et al. High dose selegiline in treatment-resistant older depressive patients. Arch Gen Psychiatry 1994;51:607-615
16. Flint AJ, Rifat SL. The effect of sequential antidepressant treatment on geriatric depression. J Affect Disord 1996;36:95-105
17. Whyte EM, Basinski J, Farhi P, et al. Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors. J Clin Psychiatry 2004;65:1634-1641
18. Flint AJ, Rifat SL. A prospective study of lithium augmentation in antidepressant-resistant geriatric depression. J Clin Psychopharmacol 1994;14:353-356
19. Reynolds CF, Frank E, Perel JM, et al. High relapse rate after discontinuation of adjunctive medication for elderly patients with recurrent major depression. Am J Psychiatry 1996;153:1418-1422
20. Uehlinger C, Nil R, Amey M, et al. Citalopram-lithium combination treatment of elderly depressed patients; a pilot study. Int J Geriatr Psychiatry 1995;10:281-287
21. Zimmer B, Rosen J, Thornton JE, et al. Adjunctive lithium carbonate in nortriptyline-resistant elderly depressed patients. J Clin Psychopharmacol 1991;11:254-256
22. Ashford JW, Ford CV. Use of MAO inhibitors in elderly patients. Am J Psychiatry 1979;136:1466-1467
23. Georgotas A, Mann J, Friedman E. Platelet monoamine oxidase inhibition as a potential indicator of favorable response to MAO-Is in geriatric depression. Biol Psychiatry 1981;16:997-1001
24. Georgotas A, Friedman E, McCarthy M, et al. Resistant geriatric depressions and therapeutic response to monoamine oxidase inhibitors. Biol Psychiatry 1983;18:195-205
25. Lazarus LW, Groves L, Gierl B, et al. Efficacy of phenelzine in geriatric depression. Biol Psychiatry 1986;21:699-701
26. Hiller W, Zaudig M, Mombour W. Development of a diagnostic checklist for use in routine clinical care. Arch Gen Psychiatry 1990;47:782-784
27. Montgomery SA, Åsberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-389
28. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State, a practical method for grading the cognitive state for the clinician. J Psychiatr Res 1975;12:189-198
29. Sackheim HA, Prudic J, Devanand DP, et al. The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol 1990;10:96-104
30. Fava M. Diagnosis and definition of treatment-resistant depression. Biol Psychiatry 2003;53:649-659
31. Burvill PW, Mowry B, Hall WD. Quantification of physical illness in psychiatric research in the elderly. Int J Geriatr Psychiatry 1990;5:161-170
32. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatr 1960;23:56-62
33. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982-1983;17:37-49
34. Guy W. Assessment Manual for Psychopharmacology. US Dept Health, Education and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976:218-222
35. Fawcett J, Epstein P, Fiester SJ, et al. Clinical management: imipramine/placebo administration manual. Psychopharmacol Bull 1987;23:309-324
36. Delis DC, Kramer JH, Kaplan E, et al. California Verbal Learning Test. Research edition. New York, NY: The Psychological Corporation Harcourt Brace Jovanovich Inc; 1987
37. Reitan R. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1958;8:271-276
38. Cole MG, Dendukuri N. Risk factors for depression among elderly community subjects: a systematic review and meta-analysis. Am J Psychiatry 2003;160:1147-1156
39. Nolen WA, Van den Broek WW, Birkenhager TK. Inadequate treatment with tranylcypromine resulted in a disappointing remission rate [letter]. Am J Psychiatry 2007;164:524
40. Dubovsky SL. Geriatric neuropsychopharmacology. In: Coffey CE, Cummings JL, eds. The American Psychiatric Press Textbook of Geriatric Neuropsychiatry, 2nd ed. Washington DC: American Psychiatric Association; 2000:569-631
41. Alexopoulos GS. Comprehensive Textbook of Geriatric Psychiatry. 3rd ed. New York, NY: WW Norton & Company, Inc; 2004
42. Austin LS, Arana GW, Melvin JE. Toxicity resulting from lithium augmentation of antidepressant treatment in elderly patients. J Clin Psychiatry 1990;51:344-345
43. Flint AJ. Recent developments in geriatric psychopharmacology. Can J Psychiatry 1994;39:S9-S18
44. Lafferman J, Solomon K, Ruskin P. Lithium augmentation for treatment-resistant depression in the elderly. J Geriatr Psychiatry Neurol 1988;1:49-52
45. Georgotas A, McCue RE, Cooper TB. A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients. Arch Gen Psychiatry 1989;46:783-786